Company that helps speed drug approvals raises $27 million
February 05, 2019 at 11:42 AM EST
Aetion, a Manhattan-based health technology company, has added $27 million to its previously announced Series B round, attracting strategic investment from several drugmakers, a drug distributor and... To view the full story, click the title link.
